Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 40 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. The latest closing stock price for Amgen as of April 30, 2024 is 273.94.
  • The all-time high Amgen stock closing price was 322.05 on February 01, 2024.
  • The Amgen 52-week high stock price is 329.72, which is 20.4% above the current share price.
  • The Amgen 52-week low stock price is 211.71, which is 22.7% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 263.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 285.8536 295.0931 322.0533 262.7500 273.9400 -4.15%
2023 244.0907 250.9133 286.2321 209.2555 285.7955 13.47%
2022 232.9374 210.7391 278.4880 205.6045 251.8626 20.43%
2021 211.6785 204.3866 235.4246 184.8859 209.1401 0.87%
2020 205.8976 210.7052 232.1817 161.0761 207.3262 -2.00%
2019 170.1339 164.6019 213.4257 144.8753 211.5564 26.70%
2018 159.2089 147.5667 178.6261 139.4555 166.9779 15.17%
2017 140.5080 122.2625 158.1735 122.2625 144.9822 22.25%
2016 124.9861 125.1258 141.4853 108.9377 118.5961 -7.55%
2015 123.7522 123.8440 138.1737 103.9567 128.2789 3.97%
2014 100.6831 87.9966 132.9450 84.6091 123.3792 42.32%
2013 78.3498 66.5115 89.8206 61.2368 86.6934 34.80%
2012 56.5099 46.9361 67.2725 46.6798 64.3106 36.80%
2011 40.7152 40.2491 47.3973 34.9743 47.0093 18.18%
2010 40.3949 41.8180 44.2993 36.4886 39.7781 -2.95%
2009 39.7892 42.7416 46.6686 32.6847 40.9881 -2.04%
2008 37.0547 33.7643 47.7410 28.9605 41.8431 24.35%
2007 41.9695 49.5596 54.9576 33.6484 33.6484 -32.02%
2006 51.1855 58.2253 58.2253 46.3136 49.4944 -13.38%
2005 50.6823 46.5745 62.4350 41.4446 57.1385 22.93%
2004 42.6767 45.1761 47.9873 38.1841 46.4803 3.82%
2003 44.5158 35.7351 51.8347 35.4163 44.7703 27.82%
2002 35.7871 40.8650 45.2703 22.5120 35.0250 -14.35%
2001 45.1503 45.5601 53.7548 37.3219 40.8939 -11.73%
2000 47.4378 45.6035 56.5154 37.1770 46.3281 6.46%
1999 26.8878 19.4543 47.0092 18.9761 43.5168 129.89%
1998 12.1047 9.7706 19.0015 8.5371 18.9290 93.05%
1997 10.0952 9.8955 12.3863 8.3324 9.8051 -0.46%
1996 10.5783 10.5512 11.7738 9.3285 9.8502 -8.42%
1995 7.3832 5.2756 10.7559 5.1171 10.7559 101.29%
1994 4.3852 4.4487 5.3779 3.2025 5.3435 19.19%
1993 3.8084 6.3959 6.4077 2.8529 4.4831 -29.91%
1992 5.8408 6.7700 7.0417 4.5284 6.3959 -6.77%
1991 4.0917 1.9246 6.8605 1.7434 6.8605 265.06%
1990 1.1926 0.7774 1.9131 0.6755 1.8793 154.10%
1989 0.6619 0.4830 0.9057 0.4811 0.7396 45.19%
1988 0.4616 0.4868 0.5396 0.3887 0.5094 8.87%
1987 0.4866 0.3567 0.6717 0.2453 0.4679 40.89%
1986 0.3053 0.1905 0.4284 0.1887 0.3321 62.95%
1985 0.1158 0.0717 0.2189 0.0697 0.2038 169.93%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.935B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $101.525B 29.23
Regeneron Pharmaceuticals (REGN) United States $97.761B 23.70
Bristol Myers Squibb (BMY) United States $89.071B 41.85
CSL (CSLLY) Australia $86.599B 0.00
GSK (GSK) United Kingdom $85.882B 10.76
Gilead Sciences (GILD) United States $81.179B 16.18
Moderna (MRNA) United States $42.235B 0.00
Biogen (BIIB) United States $31.277B 14.32
Argenex SE (ARGX) Netherlands $22.316B 0.00
BioNTech SE (BNTX) Germany $21.115B 21.56
Illumina (ILMN) United States $19.596B 141.44
Genmab (GMAB) Denmark $18.309B 23.47
Alnylam Pharmaceuticals (ALNY) United States $18.130B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.335B 59.82
BeiGene (BGNE) Cayman Islands $14.723B 0.00
Sarepta Therapeutics (SRPT) United States $11.970B 0.00
Incyte (INCY) United States $11.687B 18.07
Exact Sciences (EXAS) United States $10.912B 0.00
Bio-Techne Corp (TECH) United States $9.936B 36.97
QIAGEN (QGEN) Netherlands $9.660B 20.64
Repligen (RGEN) United States $9.169B 94.91
Roivant Sciences (ROIV) United Kingdom $8.784B 0.00
Viking Therapeutics (VKTX) United States $8.775B 0.00
Ascendis Pharma (ASND) Denmark $8.061B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Legend Biotech (LEGN) United States $7.957B 0.00
Intra-Cellular Therapies (ITCI) United States $6.952B 0.00
Exelixis (EXEL) United States $6.916B 36.66
Vaxcyte (PCVX) United States $6.585B 0.00
Cytokinetics (CYTK) United States $6.413B 0.00
Blueprint Medicines (BPMC) United States $5.590B 0.00
ImmunityBio (IBRX) United States $5.409B 0.00
Apellis Pharmaceuticals (APLS) United States $5.360B 0.00
Halozyme Therapeutics (HALO) United States $4.841B 14.94
Zealand Pharma (ZLDPF) Denmark $4.721B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.498B 0.00
Nuvalent (NUVL) United States $4.413B 0.00
Krystal Biotech (KRYS) United States $4.366B 0.00
Alkermes (ALKS) Ireland $4.152B 21.91
Immunovant (IMVT) United States $3.987B 0.00
Insmed (INSM) United States $3.672B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.535B 0.00
Axsome Therapeutics (AXSM) United States $3.503B 0.00
SpringWorks Therapeutics (SWTX) United States $3.445B 0.00
Biohaven (BHVN) United States $3.424B 0.00
Iovance Biotherapeutics (IOVA) United States $3.296B 0.00
Fortrea Holdings (FTRE) United States $3.270B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.225B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.068B 0.00
IDEAYA Biosciences (IDYA) United States $3.039B 0.00
Amicus Therapeutics (FOLD) United States $2.959B 0.00
Janux Therapeutics (JANX) United States $2.955B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.943B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.761B 0.00
Certara (CERT) United States $2.741B 59.00
CG Oncology (CGON) United States $2.678B 0.00
Arcellx (ACLX) United States $2.666B 0.00
Merus (MRUS) Netherlands $2.636B 0.00
MorphoSys AG (MOR) Germany $2.622B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.614B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.424B 0.00
Avidity Biosciences (RNA) United States $2.307B 0.00
Vericel (VCEL) United States $2.219B 0.00
Denali Therapeutics (DNLI) United States $2.201B 0.00
Guardant Health (GH) United States $2.191B 0.00
Arvinas (ARVN) United States $2.170B 0.00
Apogee Therapeutics (APGE) United States $2.159B 0.00
Vera Therapeutics (VERA) United States $2.151B 0.00
Geron (GERN) United States $2.149B 0.00
Celldex Therapeutics (CLDX) United States $2.092B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.078B 0.00
Intellia Therapeutics (NTLA) United States $2.064B 0.00
Kymera Therapeutics (KYMR) United States $2.063B 0.00
Keros Therapeutics (KROS) United States $2.034B 0.00
Sana Biotechnology (SANA) United States $1.984B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.953B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.918B 0.00
Galapagos (GLPG) Belgium $1.875B 0.00
Structure Therapeutics (GPCR) United States $1.838B 0.00
Twist Bioscience (TWST) United States $1.806B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.795B 0.00
Inhibrx (INBX) United States $1.780B 0.00
NeoGenomics (NEO) United States $1.777B 0.00
Myriad Genetics (MYGN) United States $1.771B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.755B 13.38
Beam Therapeutics (BEAM) United States $1.747B 0.00
Bavarian Nordic (BVNRY) Denmark $1.697B 5.57
Edgewise Therapeutics (EWTX) United States $1.670B 0.00
Zai Lab (ZLAB) China $1.568B 0.00
Kura Oncology (KURA) United States $1.495B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.494B 0.00
ADMA Biologics Inc (ADMA) United States $1.488B 0.00
Dynavax Technologies (DVAX) United States $1.488B 0.00
Protagonist Therapeutics (PTGX) United States $1.473B 0.00
Neumora Therapeutics (NMRA) United States $1.449B 0.00
ANI Pharmaceuticals (ANIP) United States $1.391B 17.10
Arcus Biosciences (RCUS) United States $1.385B 0.00
Akero Therapeutics (AKRO) United States $1.375B 0.00
Morphic Holding (MORF) United States $1.366B 0.00
Gyre Therapeutics (GYRE) United States $1.333B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.322B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.249B 0.00
Ligand Pharmaceuticals (LGND) United States $1.237B 15.33
Spyre Therapeutics (SYRE) United States $1.194B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.187B 0.00
Belite Bio (BLTE) United States $1.183B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.183B 0.00
Scholar Rock Holding (SRRK) United States $1.170B 0.00
Cullinan Therapeutics (CGEM) United States $1.163B 0.00
Vir Biotechnology (VIR) United States $1.138B 0.00
MannKind (MNKD) United States $1.112B 0.00
AbCellera Biologics (ABCL) Canada $1.111B 0.00
Prothena (PRTA) Ireland $1.093B 0.00
Liquidia Technologies (LQDA) United States $0.982B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.979B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.961B 0.00
Abivax SA (ABVX) France $0.944B 0.00
Praxis Precision Medicines (PRAX) United States $0.939B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.917B 0.00
MiMedx (MDXG) United States $0.909B 38.50
Tyra Biosciences (TYRA) United States $0.898B 0.00
ALX Oncology Holdings (ALXO) United States $0.851B 0.00
Viridian Therapeutics (VRDN) United States $0.846B 0.00
Immunome (IMNM) United States $0.843B 0.00
Immatics (IMTX) Germany $0.841B 0.00
Tango Therapeutics (TNGX) United States $0.822B 0.00
89BIO (ETNB) United States $0.810B 0.00
Cytek Biosciences (CTKB) United States $0.789B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.785B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.767B 0.00
Mesoblast (MESO) Australia $0.754B 0.00
PureTech Health (PRTC) United States $0.753B 0.00
REGENXBIO (RGNX) United States $0.753B 0.00
CARGO Therapeutics (CRGX) United States $0.752B 0.00
Pliant Therapeutics (PLRX) United States $0.713B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.705B 0.00
EnGene Holdings (ENGN) United States $0.693B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.689B 0.00
Disc Medicine (IRON) United States $0.672B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.669B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.667B 0.00
AnaptysBio (ANAB) United States $0.665B 0.00
HilleVax (HLVX) United States $0.656B 0.00
Pharming Group (PHAR) Netherlands $0.656B 0.00
Kyverna Therapeutics (KYTX) United States $0.653B 0.00
Nuvation Bio (NUVB) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.627B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Cogent Biosciences (COGT) United States $0.621B 0.00
Mineralys Therapeutics (MLYS) United States $0.608B 0.00
Novavax (NVAX) United States $0.608B 0.00
Zymeworks (ZYME) United States $0.605B 0.00
WAVE Life Sciences (WVE) Singapore $0.603B 0.00
Oric Pharmaceuticals (ORIC) United States $0.595B 0.00
Nurix Therapeutics (NRIX) United States $0.591B 0.00
Prime Medicine (PRME) United States $0.591B 0.00
Castle Biosciences (CSTL) United States $0.579B 0.00
Aerovate Therapeutics (AVTE) United States $0.575B 0.00
Stoke Therapeutics (STOK) United States $0.575B 0.00
GH Research (GHRS) Ireland $0.570B 0.00
Olema Pharmaceuticals (OLMA) United States $0.569B 0.00
IGM Biosciences (IGMS) United States $0.566B 0.00
CureVac (CVAC) Germany $0.564B 0.00
Northwest Biotherapeutics (NWBO) United States $0.561B 0.00
ArriVent BioPharma (AVBP) United States $0.553B 0.00
Absci (ABSI) United States $0.536B 0.00
Oculis Holding AG (OCS) Switzerland $0.529B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Adlai Nortye (ANL) Cayman Islands $0.509B 0.00
Applied Therapeutics (APLT) United States $0.505B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Shattuck Labs (STTK) United States $0.498B 0.00
Cabaletta Bio (CABA) United States $0.498B 0.00
Arbutus Biopharma (ABUS) United States $0.490B 0.00
Alector (ALEC) United States $0.490B 0.00
Avid Bioservices (CDMO) United States $0.484B 0.00
Celcuity (CELC) United States $0.480B 0.00
Allogene Therapeutics (ALLO) United States $0.471B 0.00
Humacyte (HUMA) United States $0.467B 0.00
Third Harmonic Bio (THRD) United States $0.454B 0.00
Fate Therapeutics (FATE) United States $0.450B 0.00
Neurogene (NGNE) United States $0.444B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
C4 Therapeutics (CCCC) United States $0.433B 0.00
Editas Medicine (EDIT) United States $0.428B 0.00
Voyager Therapeutics (VYGR) United States $0.425B 2.53
Travere Therapeutics (TVTX) United States $0.421B 0.00
Alto Neuroscience (ANRO) United States $0.417B 0.00
Annexon (ANNX) United States $0.415B 0.00
ACELYRIN, INC (SLRN) United States $0.413B 0.00
Entrada Therapeutics (TRDA) United States $0.399B 0.00
PepGen (PEPG) United States $0.398B 0.00
Replimune (REPL) United States $0.390B 0.00
Biomea Fusion (BMEA) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.386B 0.00
Adaptive Biotechnologies (ADPT) United States $0.386B 0.00
Mersana Therapeutics (MRSN) United States $0.385B 0.00
Anika Therapeutics (ANIK) United States $0.384B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.381B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
MaxCyte (MXCT) United States $0.379B 0.00
Amarin (AMRN) Ireland $0.378B 0.00
Revance Therapeutics (RVNC) United States $0.376B 0.00
TScan Therapeutics (TCRX) United States $0.370B 0.00
Aura Biosciences (AURA) United States $0.367B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.365B 0.00
Jasper Therapeutics (JSPR) United States $0.360B 0.00
Tenaya Therapeutics (TNYA) United States $0.356B 0.00
Erasca (ERAS) United States $0.348B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Solid Biosciences (SLDB) United States $0.336B 0.00
Nkarta (NKTX) United States $0.330B 0.00
Precigen (PGEN) United States $0.329B 0.00
Caribou Biosciences (CRBU) United States $0.328B 0.00
Terns Pharmaceuticals (TERN) United States $0.327B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Rani Therapeutics Holdings (RANI) United States $0.320B 0.00
Nautilus Biotechnology (NAUT) United States $0.318B 0.00
MeiraGTx Holdings (MGTX) United States $0.314B 0.00
Atea Pharmaceuticals (AVIR) United States $0.312B 0.00
FibroBiologics (FBLG) United States $0.308B 0.00
Kamada (KMDA) Israel $0.300B 22.70
Anavex Life Sciences (AVXL) United States $0.300B 0.00
XOMA (XOMA) United States $0.295B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.294B 0.00
CorMedix Inc (CRMD) United States $0.288B 0.00
Contineum Therapeutics (CTNM) United States $0.285B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.277B 95.20
Inozyme Pharma (INZY) United States $0.273B 0.00
Werewolf Therapeutics (HOWL) United States $0.270B 0.00
Rapt Therapeutics (RAPT) United States $0.268B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.268B 0.00
Inovio Pharmaceuticals (INO) United States $0.268B 0.00
ChromaDex (CDXC) United States $0.267B 0.00
Invivyd (IVVD) United States $0.265B 0.00
Ventyx Biosciences (VTYX) United States $0.264B 0.00
Verastem (VSTM) United States $0.253B 0.00
Agenus (AGEN) United States $0.246B 0.00
AC Immune (ACIU) Switzerland $0.245B 0.00
Puma Biotechnology (PBYI) United States $0.244B 11.02
23andMe Holding (ME) United States $0.243B 0.00
Prima BioMed (IMMP) Australia $0.237B 0.00
Poseida Therapeutics (PSTX) United States $0.235B 0.00
2seventy Bio (TSVT) United States $0.234B 0.00
XBiotech (XBIT) United States $0.234B 0.00
Renovaro (RENB) United States $0.227B 0.00
Coherus BioSciences (CHRS) United States $0.222B 0.00
Ovid Therapeutics (OVID) United States $0.216B 0.00
INmune Bio (INMB) United States $0.216B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.212B 0.00
UniQure (QURE) Netherlands $0.211B 0.00
Candel Therapeutics (CADL) United States $0.207B 0.00
Trevi Therapeutics (TRVI) United States $0.206B 0.00
Codexis (CDXS) United States $0.205B 0.00
Adverum Biotechnologies (ADVM) United States $0.202B 0.00
Design Therapeutics (DSGN) United States $0.199B 0.00
Compass Therapeutics (CMPX) United States $0.198B 0.00
G1 Therapeutics (GTHX) United States $0.197B 0.00
Opthea (OPT) Australia $0.195B 0.00
Cardiff Oncology (CRDF) United States $0.195B 0.00
Lifecore Biomedical (LFCR) United States $0.195B 0.00
Elevation Oncology (ELEV) United States $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.193B 0.00
Alimera Sciences (ALIM) United States $0.193B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
X4 Pharmaceuticals (XFOR) United States $0.188B 0.00
Innate Pharma S.A (IPHA) France $0.187B 0.00
Zura Bio (ZURA) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.169B 0.00
Compugen (CGEN) Israel $0.167B 0.00
ScPharmaceuticals (SCPH) United States $0.161B 0.00
Inventiva S.A (IVA) France $0.161B 0.00
Gossamer Bio (GOSS) United States $0.161B 0.00
Greenwich LifeSciences (GLSI) United States $0.160B 0.00
Skye Bioscience (SKYE) United States $0.160B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.158B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.158B 0.00
CervoMed (CRVO) United States $0.150B 0.00
Seres Therapeutics (MCRB) United States $0.150B 0.00
BioStem Technologies (BSEM) $0.147B 0.00
Syros Pharmaceuticals (SYRS) United States $0.144B 0.00
I-Mab (IMAB) China $0.143B 0.00
Cellectis S.A (CLLS) France $0.142B 0.00
Scilex Holding (SCLX) United States $0.142B 0.00
Molecular Partners AG (MOLN) Switzerland $0.138B 0.00
Seer (SEER) United States $0.135B 0.00
Coya Therapeutics (COYA) United States $0.132B 0.00
Repare Therapeutics (RPTX) Canada $0.132B 0.00
VistaGen Therapeutics (VTGN) United States $0.131B 0.00
DBV Technologies S.A (DBVT) France $0.128B 0.00
Sagimet Biosciences (SGMT) United States $0.124B 0.00
Omega Therapeutics (OMGA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.123B 0.00
Adicet Bio (ACET) United States $0.122B 0.00
Cartesian Therapeutics (RNAC) United States $0.119B 0.00
Vor Biopharma (VOR) $0.117B 0.00
Oncobiologics (OTLK) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Abeona Therapeutics (ABEO) United States $0.113B 0.00
Nuvectis Pharma (NVCT) United States $0.112B 0.00
TELA Bio (TELA) United States $0.111B 0.00
CytomX Therapeutics (CTMX) United States $0.110B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Rezolute (RZLT) United States $0.108B 0.00
Sangamo Therapeutics (SGMO) United States $0.107B 0.00
ATyr Pharma (LIFE) United States $0.107B 0.00
Adagene (ADAG) China $0.100B 0.00
Emergent Biosolutions (EBS) United States $0.099B 0.00
Vigil Neuroscience (VIGL) United States $0.098B 0.00
Bluebird Bio (BLUE) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.094B 0.00
BioHarvest Sciences (CNVCF) Canada $0.094B 0.00
BioXcel Therapeutics (BTAI) United States $0.093B 0.00
Allakos (ALLK) United States $0.093B 0.00
Cue Biopharma (CUE) United States $0.092B 0.00
Curis (CRIS) United States $0.090B 0.00
Eton Pharmaceuticals (ETON) United States $0.090B 0.00
Q32 Bio (QTTB) United States $0.089B 0.00
HOOKIPA Pharma (HOOK) United States $0.088B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
Gritstone Bio (GRTS) United States $0.086B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Oncolytics Biotech (ONCY) Canada $0.084B 0.00
Genelux (GNLX) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.083B 0.00
Affimed (AFMD) Germany $0.081B 0.00
InflaRx (IFRX) Germany $0.081B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.080B 0.00
Passage Bio (PASG) United States $0.079B 0.00
Leap Therapeutics (LPTX) United States $0.079B 0.00
BeyondSpring (BYSI) United States $0.078B 0.00
Aileron Therapeutics (ALRN) United States $0.077B 0.00
Connect Biopharma Holdings (CNTB) United States $0.077B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.84
Cognition Therapeutics (CGTX) United States $0.076B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.076B 0.00
Athira Pharma (ATHA) United States $0.076B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.074B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
Rallybio (RLYB) United States $0.073B 0.00
Precision BioSciences (DTIL) United States $0.072B 0.00
Galena Biopharma (SLS) United States $0.072B 0.00
AN2 Therapeutics (ANTX) United States $0.072B 0.00
Instil Bio (TIL) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.069B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.067B 0.00
Elutia (ELUT) United States $0.067B 0.00
YS Biopharma (YS) China $0.066B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
MediciNova (MNOV) United States $0.063B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
CalciMedica (CALC) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.061B 0.00
Turnstone Biologics (TSBX) United States $0.060B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.059B 0.00
Bionano Genomics (BNGO) United States $0.059B 0.00
Celularity (CELU) United States $0.059B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Aligos Therapeutics (ALGS) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.056B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Clene (CLNN) United States $0.055B 0.00
Lantern Pharma (LTRN) United States $0.055B 0.00
Cidara Therapeutics (CDTX) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
HCW Biologics (HCWB) United States $0.053B 0.00
Equillium (EQ) United States $0.053B 0.00
ARCA Biopharma (ABIO) United States $0.051B 0.00
Checkpoint Therapeutics (CKPT) United States $0.050B 0.00
Ocean Biomedical (OCEA) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Prenetics Global (PRE) Cayman Islands $0.046B 0.00
OKYO Pharma (OKYO) $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
Dyadic (DYAI) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.041B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.040B 0.00
Beyond Air (XAIR) United States $0.039B 0.00
Carmell (CTCX) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Apollomics (APLM) United States $0.038B 0.00
Promis Neurosciences (PMN) Canada $0.038B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
NKGen Biotech (NKGN) United States $0.034B 0.00
NextCure (NXTC) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.030B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Femasys (FEMY) United States $0.028B 0.00
Aprea Therapeutics (APRE) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Synlogic (SYBX) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Senti Biosciences (SNTI) United States $0.016B 0.00
VBI Vaccines (VBIV) United States $0.016B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.016B 0.00
Semper Paratus Acquisition (TVGN) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Telesis Bio (TBIO) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Psyence Biomedical (PBM) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Kineta (KA) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Cingulate (CING) United States $0.006B 0.00
Novogen (KZIA) Australia $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
First Wave BioPharma (FWBI) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Exicure (XCUR) United States $0.004B 0.31
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Bright Minds Biosciences (DRUG) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00